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Lentigo maligna · Extrafacial location · Early diagnosis
Abstract
Introduction: Lentigo maligna (LM) is a rare form of in situ 
melanoma, frequently seen as a large patch in elderly pa-
tients. The aim of this study was to assess clinical and dermo-
scopic features of LM. Material and Methods: A retrospec-
tive study of LM patients presenting to our center between 
July 2007 and July 2017 was performed. Demographic data, 
anatomical location, laterality, diameter, Clark level, Breslow 
stage, “ABCD” signs and dermoscopic features were regis-
tered. Facial versus extrafacial LM were compared. Results: 
We found 21 LM, of which 12 had an extrafacial location and 
9 a facial location. Half of the extrafacial lesions were located 
on an upper limb. The median age at diagnosis was 63 years 
(ranging from 38 to 84 years). Most LM cases were female 
(16/21) with phototype II (13/21). More than half of the pa-
tients (11/21) had a history of a skin neoplasm or actinic ker-
atosis. The median diameter found was 6 mm (interquartile 
range = 4.5 mm), ranging from 1 to 15 mm. Five lesions were 
invasive (median Breslow depth of 0.2 mm), and 4 of them 
were extrafacial. Discussion: In this study LM was more fre-
quently found in an extrafacial location and as a small patch 
with a 6-mm diameter medium. The epidemiology of LM/LM 
melanoma might be changing. Full body examination and 
dermoscopy are of the utmost importance for the diagnosis. 
Dermatologists should be aware and search for small lesions 
outside the face and neck, particularly in middle-aged fe-
male patients with photo-damaged skin.
© 2018 S. Karger AG, Basel
Introduction
Lentigo maligna (LM) is relatively rare form of ma-
lignant melanoma (MM), corresponding to 4–15% of 
all MM cases [1]. LM usually occurs in sun-damaged 
skin and is typically poorly circumscribed; its diagnosis 
is based on atypical junctional melanocytic hyperplasia 
combined with solar elastosis and epidermal atrophy 
[1, 2]. When LM invades the dermis, it is called lentigo 
maligna melanoma (LMM). The exact percentage of 






LM occurs almost exclusively in middle-aged and el-
derly Caucasians [2]; its incidence is increasing because 
of a higher cumulative exposure to ultraviolet radiation 
[4]. Classically, LM presents as a slowly enlarging patch 
with variable color and with ill-defined borders, most fre-
quently located on the head and neck (86%), with predi-
lection for the cheeks [5]. 
The clinical presentation may be subtle, particularly in 
early stages, and therefore, delayed diagnosis is common 
[4]. Because of its potential significant subclinical exten-
sion, LM has a higher risk of local recurrence than other 
types of correctly treated melanoma. Once LM progresses 
to its vertically invasive form, its prognosis is similar to that 
of other types of MM. The diagnosis is a challenge in most 
Patients with melanoma (n = 152)
between 2007 and 2017 at our center
Patients with lentigo maligna (n = 21)
between 2007 and 2017 at our center
Clinical features (n = 21)
Dermoscopic features (n = 20)
a
b c
Fig. 1. Flowchart of the Methods.
Fig. 2. Lentigo maligna. a Hyperpigmented patch, 3 mm in diameter, on the left arm, in a photo-damaged area, 
of a woman in her sixties. b Dermoscopy (×30): atypical pigmented network, irregular striae. c Histopathology 
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Male 1 (11.1) 4 (33.3) 5 (23.8)
Female 8 (88.9) 8 (66.7) 16 (76.2)
Age (median, IQR), years 63 (10) 64 (16) 63 (15)
Working status, n (%)
Active 6 (66.7) 8 (66.7) 14 (66.7)
Retired 3 (33.3) 4 (33.3) 7 (33.3)
History of living in a tropical country, n (%) 2 (22.2) 0 (0) 2 (9.5)
Immunosuppressive therapy, n (%) 0 (0) 0 (0) 0 (0)
Phototype, n (%)
I 1 (11.1) 1 (8.3) 2 (9.5)
II 5 (55.6) 8 (66.7) 13 (61.9)
III 3 (33.3) 3 (25.0) 6 (28.6)
Number of nevi, n (%)
<25 6 (66.7) 7 (58.3) 13 (61.9)
25–50 1 (11.1) 5 (41.7) 6 (28.6)
51–100 2 (22.2) 0 (0) 2 (9.5) 
Guttate hypomelanosis, n (%) 8 (88.9) 8 (66.7) 16 (76.2)
History of other neoplasms/lesions, n (%) 5 (55.6) 7 (58.3) 12 (57.1)
Melanoma 1 (11.1) 0 (0) 1 (4.8)
Basal cell carcinoma 3 (33.3) 2 (16.7) 5 (23.8)
Squamous cell carcinoma 2 (22.2) 2 (16.7) 4 (19.0) 
Actinic keratosis 5 (55.6) 6 (50.0) 11 (52.4)
Other neoplasmsa 1 (11.1) 1 (8.3) 2 (9.5)
Family history of skin neoplasmsb, n (%) 1 (14.3) 0 (0) 1 (6.2)
Melanoma 0 (0) 0 (0) 0 (0)
Basal cell carcinoma 1 (14.3) 0 (0) 1 (6.2)
Squamous cell carcinoma 1 (14.3) 0 (0) 1 (6.2) 
Solar lentigo, n (%) 8 (88.9) 12 (100) 20 (95.2)
Laterality, n (%)
Left 5 (55.6) 5 (41.7) 10 (47.6)
Right 2 (22.2) 7 (58.3) 9 (42.9)
Nonapplicable 2 (22.2) 0 (0) 2 (9.5)
Diameter (median, IQR), mm 5.6 (3.2) 5.0 (3.3) 6.0 (4.5)
Diameter >12 mm 3 (33.3) 0 (0) 3 (14.3)
Invasive LMc, n (%) 1 (11.1) 4 (33.3) 5 (23.8)
Breslow depthc (median, IQR), mm 0.4 (0) 0.2 (0.1) 0.2 (0.1)
Amelanotic LM, n (%) 2 (22.2) 1 (8.3) 3 (14.3)
“ABCDE” signs, n (%) 9 (100) d 11 (81.7) d 20 (95.2) d
Asymmetry 5 (55.6) 7 (58.3) 12 (57.1)
Border 6 (66.7) 8 (66.7) 14 (66.7)
Color 1 (11.1) 5 (41.7) 6 (28.6)
Diameter ≥6 mm 6 (66.7) 5 (41.7) 11 (52.4)
Evolution
Evolving lesion 3 (33.3) 3 (25.0) 6 (28.6)
De novo lesion 0 (0) 3 (25.0) 3 (14.3)
Stable lesion 0 (0) 0 (0) 0 (0)





cases. Suspicious lesions should undergo dermoscopic 
evaluation that may contribute to an early diagnosis [6]. 
The aim of this study was to characterize the clinical 
and dermoscopic features of LM/LMM in our center dur-
ing the last decade. 
Methods
For further details, see the online supplementary material (see 
www.karger.com/doi/10.1159/000489397 for all online suppl. ma-
terial) (Fig. 1).
Results
Over the assessed 10-year period, we observed a total 
of 21 LM (out of 152 melanomas observed within the 
same period), of which 12 had an extrafacial location. 
Half of the latter were located on the upper limbs (upper 
arm: n = 3; forearm: n = 2; hand: n = 1; Fig. 2), followed 
by the lower limbs (lower leg: n = 4; thigh: n = 1) and the 
upper back (n = 1). In all patients, LM was first suspected 
by a dermatologist. The median age at diagnosis was 63 
years (ranging from 38 to 84 years).
Most LM cases were female (16/21) and occurred in 
patients with phototype II (13/21) and less than 25 nevi 
(13/21) (Table 1). More than half of the patients (11/21) 
had a history of a skin neoplasm or actinic keratosis. The 
median diameter for the assessed LM was 6 mm (inter-
quartile range, IQR = 4.5 mm – ranging from 1 to 15 mm), 
corresponding to a median diameter of 5.1 mm among 
females (IQR = 5.3 mm) and 8.0 mm among males 
(IQR = 2.5 mm).
Of the “ABCD” signs, asymmetry, irregular border 
and diameter ≥5 mm were observed in more than half of 
the neoplasms; however, the presence of at least 3 ABCD 
signs was only present in 2 out of 6 cases of LM with di-








Dermoscopic findingse, n (%)
Atypical pigment network 1 (11.1) 10 (90.9) 11 (55.0)
Disappearance of follicular structures 7 (77.8) 0 (0) 7 (35.0)
White striae 1 (11.1) 0 (0) 1 (5.0)
Irregular pseudopods 0 (0) 3 (27.3) 3 (15.0)
Annular-granular pattern 6 (66.7) 0 (0) 6 (30.0)
Rhomboidal structures 3 (33.3) 0 (0) 3 (15.0)
Milky red areas 2 (22.2) 2 (18.2) 4 (20.0)
Multicomponent, ≥3 structures 6 (66.7) 1 (9.1) 7 (35.0)
Peppering 2 (22.2) 3 (27.3) 5 (25.0)
Irregular follicular pigmentation 6 (66.7) 0 (0) 6 (30.0)
Irregular dots/globules 0 (0) 2 (18.2) 2 (10.0)
Gray pseudonetwork 2 (22.2) 0 (0) 2 (10.0)
Angulated lines 1 (11.1) 0 (0) 1 (5.0)
Polymorph vessels, ≥2 types 2 (22.2) 0 (0) 2 (10.0)
Dot vessels 1 (11.1) 1 (9.1) 2 (10.0)
Hook vessels 0 (0) 0 (0) 0 (0)
Glomerular vessels 0 (0) 1 (9.1) 1 (5.0)
Irregular linear vessels 2 (22.2) 1 (9.1) 3 (15.0)
Helicoidal vessels 2 (22.2) 0 (0) 2 (10.0)
IQR, interquartile range. a Includes 1 patient with a history of thyroid cancer and another with a history of 
leiomyoma. b Family history of melanoma is unknown for 6 patients, while family history of basal cell carcinoma 
and squamous cell carcinoma is unknown for 5 patients. c All invasive LM were staged as Clark level II and Bre-
slow stage I. d Frequency of patients presenting with at least 1 “ABCDE” sign. For facial LM, 1/3 of patients only 
presented with 1 “ABCDE” sign, while 2/3 of them presented with 2 or more criteria. For extrafacial LM, 17% of 
patients only presented with 1 sign, while 75% presented with 2 or more signs. e Dermoscopic information not 
available for 1 patient.
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ic findings were atypical pigment network (11/20), dis-
appearance of follicular structures (7/20) and multicom-
ponent pattern (7/20) (Table 1). Five lesions were inva- 
sive – LMM – all of them staged as Clark level II, having 
a median Breslow depth of 0.2 mm (IQR = 0.1 mm).
Facial LM were observed for half of the female patients 
(8/16) but for only one fifth (1/5) of male patients. Results 
of the comparisons between facial versus extrafacial LM, 
and between neoplasms of < 5 versus ≥5 mm diameter are 
presented in Table 1 and Table 2, respectively. 
Discussion
Despite being a small retrospective series of a single 
center, this study has some interesting results, particu-
larly regarding the location and median diameter of the 
assessed neoplasm, as well as the patients’ median age.
In fact, in our study, almost 60% of LM were located 
outside the face and neck. Extrafacial location had been 
reported by previous studies, but never to such an extent. 
In most studies, LM involving the head and neck account-
ed for 75–85%, and only 15–25% were outside the face 
and neck. Patient age and gender distribution were also 
surprisingly different from those usually described in the 
literature [5, 7] in this study, the median age was lower 
than usually reported (63 vs. 70–75 years) [7]. In addition, 
more than three quarters of our patients were female, 
while most previous studies had reported LM to be more 
common among males [5, 7].
Changing patterns of sun exposure may contribute to 
the changing epidemiology of LM. The face is consistent-
ly more exposed than other areas, but the relationship 
between sun exposure and LM/LMM might be complex. 
The regular use of sunscreens on the face may not totally 
explain the higher incidence of extrafacial lesions, be-
Table 2. Comparison of the frequency of “ABCDE” signs and dermoscopic findings in lentigo maligna (LM) 
cases with <5 and ≥5 mm diameter
LM with diameter
<5 mm (n = 6)
LM with diameter
≥5 mm (n = 12)
Total 
(n = 21)
“ABCDE” signs, n (%) 2 (33.3)a 10 (66.7)a 12 (57.1)a
Asymmetry 2 (33.3) 10 (66.7) 12 (57.1)
Border 3 (50.0) 11 (73.3) 14 (66.7)
Color 2 (33.3) 4 (26.7) 6 (28.6)
Diameter ≥6 mm 0 (0) 11 (73.3) 11 (52.4)
Evolutionb 4 (66.7) 5 (33.3) 9 (42.9)
Dermoscopic findingsc, n (%)
Atypical pigment network 5 (83.3) 6 (42.9) 11 (55.0)
Disappearance of follicular structures 1 (16.7) 6 (42.9) 7 (35.0)
White striae 0 (0) 1 (7.1) 1 (5.0)
Irregular pseudopods 1 (16.7) 2 (14.3) 3 (15.0)
Annular-granular pattern 1 (16.7) 5 (35.7) 6 (30.0)
Rhomboidal structures 0 (0) 3 (21.4) 3 (15.0)
Milky red areas 1 (16.7) 3 (21.4) 4 (20.0)
Multicomponent, ≥3 structures 1 (16.7) 6 (42.9) 7 (35.0)
Peppering 2 (33.3) 3 (21.4) 5 (25.0)
Irregular follicular pigmentation 1 (16.7) 5 (35.7) 6 (30.0)
Irregular dots/globules 1 (16.7) 1 (7.1) 2 (10.0)
Gray pseudonetwork 0 (0) 2 (14.3) 2 (10.0)
Angulated lines 0 (0) 1 (7.1) 1 (5.0)
Polymorph vessels, ≥2 types 0 (0) 2 (14.3) 2 (10.0)
Dot vessels 1 (16.7) 1 (7.1) 2 (10.0)
Hook vessels 0 (0) 0 (0) 0 (0)
Glomerular vessels 0 (0) 1 (7.1) 1 (5.0)
Irregular linear vessels 0 (0) 3 (21.4) 3 (15.0)
Helicoidal vessels 0 (0) 2 (14.3) 2 (10.0)





cause females typically use more sunscreen all over the 
year than males (among whom we only found 1 facial le-
sion). 
The median diameter at diagnosis was very small (me-
dian of 6 mm; 9 lesions with ≤5 mm). The bigger lesion 
observed had 15 mm and was smaller than the mean di-
ameter found in a Spanish study (15.8 mm) [7]. Females 
had a smaller median diameter than males, suggesting a 
more delayed diagnosis among the latter. 
Although the “ABCD” criteria have a good semiologi-
cal value in the differential diagnosis of pigmented lesions 
[8], in this study only 2 cases of LM < 5 mm had 3 signs of 
this rule, which does therefore not seem to be useful for 
the diagnosis of early small lesions.
Dermoscopy of facial pigmented lesions has been 
widely studied [4, 9, 10]. In our series, the most frequent 
feature for facial LM (particularly in lesions ≥5 mm) were 
disappearance of follicular structures, annular granular 
pattern and irregular follicular pigmentation, but also 
multicomponent pattern. Dermoscopic features of extra-
facial LM include a combination of features of facial LM 
and in situ superficial spreading MM [9]. None of the ex-
trafacial cases of this series had a single feature of facial 
LM. Curiously, only 1 case of angulated lines was found; 
it concerned a facial LM, and not an extrafacial lesion, 
where this pattern has been previously reported [11].
Reflectance confocal microscopy has been described as 
an important complementary tool for diagnosis, treat-
ment guidance and follow-up of LM [12, 13], but it is a 
time-consuming and highly costly technique. Although 
more sensitive, it is less specific for the diagnosis of LM 
[14].
A routine full-body examination of the patients, and a 
regular photographic documentation with dermoscopy 
[15], associated with higher suspicions on patients with 
photo damage or a skin cancer history, may justify the 
small diameter of the lesions in this study. Clinical suspi-
cion supported by complete history and close inspection 
assisted by dermoscopy are of most importance to recog-
nize early LM. 
Key Message
60% of lentigo maligna are located in photo-exposed areas out-
side the head and neck.
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